Lyxor Core MSCI World UCITS ETF
- ISIN
- LU1781541179
- Issuer
- Amundi
- TER
- 0.12%
- Latest closing price
- N/A
- Fund Size
- €5.1 bn As of: Sep 20, 2026
- Domicile
- Luxembourg
- Distribution Policy
- Accumulating
- Replication Method
- Physical
- Base Currency
- USD
- WKN / Ticker
- N/A / LYX0YD
Data availability
Data is available for 2 of 5 areas for this fund.
- Master data (TER, index, size): As of: Sep 20, 2026
- Closing price: not available
- Price history (at least 20 prices): not available
- Holdings: As of: Apr 8, 2026
- Risk figures: not available
Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.
At a glance
Data as ofLyxor Core MSCI World UCITS ETF (ISIN LU1781541179) is a fund from Amundi (fund type: ETF). Benchmark index: MSCI World. Its ongoing charges (TER) are 0.12% per year. The fund size is €5.1 bn. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Luxembourg.
- Base Currency USD
- Distribution Policy Accumulating
- Replication Method Physical
- Domicile LU
- UCITS Compliant Yes
Price development
Comparison line: MSCI World – ETF used as a proxy for the index, USDPure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.
Risk figures (12 months)
No calculated risk figures are available for this fund yet.
The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.
Documents
We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.
Search documents at AmundiTracking difference and tracking error
For MSCI World we only have a comparison series of the type “ETF used as a proxy for the index” in USD. No meaningful tracking difference can be calculated from it, because dividends, currency effects or the costs of a proxy ETF would distort the result. The issuer’s reports contain tracking difference figures.
What does the fund invest in?
Calculated from the largest holdings – covers only part of the fund.
Sector Breakdown
-
Technology 16.6%
-
Telecommunication 4.8%
-
Consumer discretionary 4.7%
-
Health care 3.3%
-
Financials 1.1%
-
Consumer staples 0.6%
Country Breakdown
-
United States 27.2%
-
Switzerland 1.1%
-
Netherlands 0.6%
-
Denmark 0.6%
-
Germany 0.5%
-
Japan 0.4%
-
United Kingdom 0.4%
-
France 0.4%
Holdings
Showing 20 holdings that together make up 31.2 % of fund assets. The total number of holdings in the fund is not recorded here; see the issuer’s factsheet.
This holdings list comes from a bundled file without a documented source or as-of date. It may be outdated; the issuer’s current holdings list is authoritative.
| # | Name | ISIN | Sector | Country | Weight |
|---|---|---|---|---|---|
| 1 | Apple Inc | US0378331005 | Technology | United States | 5.16 % |
| 2 | Microsoft Corp | US5949181045 | Technology | United States | 4.83 % |
| 3 | NVIDIA Corp | US67066G1040 | Technology | United States | 4.19 % |
| 4 | Amazon.com Inc | US0231351067 | Consumer discretionary | United States | 2.73 % |
| 5 | Meta Platforms Inc | US30303M1027 | Telecommunication | United States | 1.89 % |
| 6 | Alphabet Inc A | US02079K3059 | Telecommunication | United States | 1.56 % |
| 7 | Alphabet Inc C | US02079K1079 | Telecommunication | United States | 1.39 % |
| 8 | Broadcom Inc | US11135F1012 | Technology | United States | 1.33 % |
| 9 | Tesla Inc | US88160R1014 | Consumer discretionary | United States | 1.19 % |
| 10 | JPMorgan Chase & Co | US46625H1005 | Financials | United States | 1.06 % |
| 11 | Eli Lilly & Co | US5324571083 | Health care | United States | 0.99 % |
| 12 | UnitedHealth Group Inc | US91324P1021 | Health care | United States | 0.89 % |
| 13 | Nestlé SA | CH0038863350 | Consumer staples | Switzerland | 0.63 % |
| 14 | ASML Holding NV | NL0010273215 | Technology | Netherlands | 0.59 % |
| 15 | Novo Nordisk A/S | DK0062498333 | Health care | Denmark | 0.56 % |
| 16 | Roche Holding AG | CH0012032048 | Health care | Switzerland | 0.49 % |
| 17 | SAP SE | DE0007164600 | Technology | Germany | 0.46 % |
| 18 | Toyota Motor Corp | JP3633400001 | Consumer discretionary | Japan | 0.43 % |
| 19 | AstraZeneca PLC | GB0009895292 | Health care | United Kingdom | 0.41 % |
| 20 | LVMH Moët Hennessy | FR0000121014 | Consumer discretionary | France | 0.39 % |
Country and sector breakdowns refer only to the holdings shown (31.2 % of fund assets), not to the whole fund.
Country Breakdown
- US 27.2 %
- CH 1.1 %
- NL 0.6 %
- DK 0.6 %
- DE 0.5 %
- JP 0.4 %
- GB 0.4 %
- FR 0.4 %
Sector Breakdown
- Technology 16.6 %
- Communication Services 4.8 %
- Consumer Discretionary 4.7 %
- Healthcare 3.3 %
- Financials 1.1 %
- Consumer Staples 0.6 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.
Alternatives on the same index
Other ETFs tracking the MSCI World – cheapest first.| Name | TER | Fund Volume | Distribution |
|---|---|---|---|
| Lyxor Core MSCI World UCITS ETF This fund | 0.12% | €5.1 bn | Accumulating |
| Invesco MSCI World UCITS ETF | 0.05% | €8.5 bn | Accumulating |
| BNP Paribas Easy MSCI World UCITS ETF EUR Acc | 0.05% | €187 m | Accumulating |
| BNP Paribas Easy MSCI World UCITS ETF USD Acc | 0.05% | €41 m | Accumulating |
| UBS Core MSCI World UCITS ETF USD acc | 0.06% | €10.7 bn | Accumulating |
| UBS Core MSCI World UCITS ETF USD dis | 0.06% | €2.0 bn | Distributing |
| BNP Paribas Easy MSCI World II UCITS ETF Acc New launch | 0.08% | €57 m | Accumulating |
Available Share Classes
-
Lyxor Core MSCI World UCITS ETF
ISIN: LU1781541179 | Base Currency: USD
Frequently asked questions about the Lyxor Core MSCI World UCITS ETF
All information without guarantee. It is provided for information purposes only and does not constitute investment advice.